BR100 Decreased By (-1.08%)
BR30 Decreased By (-1.33%)
KSE100 Decreased By (-0.64%)
KSE30 Decreased By (-0.81%)
BECO 5.32 Decreased By ▼ -0.11 (-2.03%)
BML 55.27 Decreased By ▼ -0.42 (-0.75%)
BOP 35.00 Decreased By ▼ -0.38 (-1.07%)
CNERGY 8.16 Decreased By ▼ -0.04 (-0.49%)
DCL 11.40 Decreased By ▼ -0.15 (-1.3%)
FCCL 57.51 Decreased By ▼ -0.85 (-1.46%)
FCSC 5.00 Decreased By ▼ -0.12 (-2.34%)
FFL 17.66 Decreased By ▼ -0.18 (-1.01%)
FNEL 1.23 Decreased By ▼ -0.02 (-1.6%)
HUMNL 10.90 Decreased By ▼ -0.17 (-1.54%)
KEL 8.56 Decreased By ▼ -0.19 (-2.17%)
KOSM 6.47 Decreased By ▼ -0.22 (-3.29%)
MLCF 106.59 Decreased By ▼ -0.56 (-0.52%)
NBP 199.00 Decreased By ▼ -2.73 (-1.35%)
PACE 11.06 Decreased By ▼ -0.24 (-2.12%)
PAEL 44.95 Increased By ▲ 0.46 (1.03%)
PIAHCLA 28.37 Decreased By ▼ -1.04 (-3.54%)
PIBTL 18.28 Decreased By ▼ -0.36 (-1.93%)
PPL 243.50 Decreased By ▼ -4.48 (-1.81%)
PRL 34.91 Decreased By ▼ -0.38 (-1.08%)
PTC 65.25 Decreased By ▼ -0.89 (-1.35%)
SEARL 94.00 Decreased By ▼ -1.49 (-1.56%)
SSGC 30.75 Decreased By ▼ -1.29 (-4.03%)
TELE 8.69 Decreased By ▼ -0.18 (-2.03%)
THCCL 64.86 Decreased By ▼ -1.75 (-2.63%)
TPLP 10.22 Decreased By ▼ -0.35 (-3.31%)
TREET 25.04 Decreased By ▼ -0.26 (-1.03%)
TRG 63.15 Decreased By ▼ -1.25 (-1.94%)
WAVES 10.64 Decreased By ▼ -0.26 (-2.39%)
WTL 1.25 Decreased By ▼ -0.01 (-0.79%)
World

Canada reports first case of rare blood clotting after AstraZeneca COVID shot

  • The person, who was not identified and who received the inoculation produced at the Serum Institute of India, is at home and recovering.
Published April 13, 2021 Updated April 14, 2021
By

OTTAWA: Canada on Tuesday said it had recorded its first case of blood clotting with low platelets after someone received the AstraZeneca COVID-19 shot, according to a Health Ministry statement.

The person, who was not identified and who received the inoculation produced at the Serum Institute of India, is at home and recovering.

Canada has limited the use of the AstraZeneca vaccine to those above 55 due to concern about the rare reaction.

Comments

Comments are closed for this article.